Fried EI, van Borkulo CD, Cramer AOJ, Boschloo L, Schoevers RA, Borsboom D. Mental disorders as networks of problems: a review of recent insights. Soc Psychiatry Psychiatr Epidemiol. 2017;52:1–10.
Cramer AOJ, Waldorp LJ, Van Der Maas HLJ, Borsboom D. Comorbidity: a network perspective. Behav Brain Sci. 2010;33:137–50.
Bringmann LF, Lemmens LHJM, Huibers MJH, Borsboom D, Tuerlinckx F. Revealing the dynamic network structure of the Beck depression inventory-II. Psychol Med. 2015;45:747–57.
Airaksinen J, Gluschkoff K, Kivimäki M, Jokela M. Connectivity of depression symptoms before and after diagnosis of a chronic disease: a network analysis in the U.S. health and retirement study. J Affect Disord. 2020;266:230–4.
Hakulinen C, Fried EI, Pulkki-Råback L, Virtanen M, Suvisaari J, Elovainio M. Network structure of depression symptomology in participants with and without depressive disorder: the population-based Health 2000–2011 study. Soc Psychiatry Psychiatr Epidemiol. 2020. https://doi.org/10.1007/s00127-020-01843-7.
Bos FM, Fried EI, Hollon SD, Bringmann LF, Dimidjian S, DeRubeis RJ, et al. Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment. Soc Psychiatry Psychiatr Epidemiol. 2018;53:617–27.
van Borkulo C, Boschloo L, Borsboom D, Penninx BWJH, Waldorp LJ, Schoevers RA. Association of symptom network structure with the course of depression. JAMA Psychiatry. 2015;72:1219–26.
Groen RN, Snippe E, Bringmann LF, Simons CJP, Hartmann JA, Bos EH, et al. Capturing the risk of persisting depressive symptoms: A dynamic network investigation of patients’ daily symptom experiences. Psychiatry Res. 2019;271:640–8.
Fried EI, Nesse RM. Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential. BMC Med. 2015;13:72.
Hieronymus F, Emilsson JF, Nilsson S, Eriksson E. Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry. 2016;21:523–30.
Hieronymus F, Nilsson S, Eriksson E. A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors. Transl Psychiatry. 2016;6:e834.
Blanken TF, Van Der Zweerde T, Van Straten A, Van Someren EJW, Borsboom D, Lancee J. Introducing network intervention analysis to investigate sequential, symptom-specific treatment effects: a demonstration in co-occurring insomnia and depression. Psychother Psychosom. 2019;88:52–4.
World Health Organization. ICD-10: International statistical classification of diseases and related health problems: tenth revision, 2nd edn. World Health Organization; 2004.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. American Psychiatric Association; 2013.
Serafini G. Neuroplasticity and major depression, the role of modern antidepressant drugs. World J Psychiatry. 2012;2:49–57.
Dew MA, Reynolds CF, Houck PR, Hall M, Buysse DJ, Frank E, et al. Temporal profiles of the course of depression during treatment predictors. Arch Gen Pyschiatry. 1997;54:1016–24.
Pigeon WR, Hegel M, Unützer J, Fan M-Y, Sateia MJ, Lyness JM, et al. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? Sleep. 2008;31:481–8.
Wichniak A, Wierzbicka A, Walęcka M, Jernajczyk W. Effects of antidepressants on sleep. Curr Psychiatry Rep. 2017;19:63.
Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL, Manson CCF, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD010753.pub2.
García-Velázquez R, Jokela M, Rosenström TH. Direction of dependence between specific symptoms of depression: a non-gaussian approach. Clin Psychol Sci. 2019;8:240–51.
Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf. 1993;8:186–212.
Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160:790–2.
Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. Arch Gen Psychiatry. 2000;57:311.
Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163:41–7.
Schistermann EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20:488–95.
Bringmann LF, Elmer T, Epskamp S, Krause RW, Schoch D, Wichers M, et al. What do centrality measures measure in psychological networks? J Abnorm Psychol. 2019;128:892–903.
Fisher AJ, Reeves JW, Lawyer G, Medaglia JD, Rubel JA. Exploring the idiographic dynamics of mood and anxiety via network analysis. J Abnorm Psychol. 2017;126:1044–56.
Fisher AJ, Medaglia JD, Jeronimus BF. Lack of group-to-individual generalizability is a threat to human subjects research. Proc Natl Acad Sci. 2018;115:E6106–15.
Molenaar PCM. On the implications of the classical ergodic theorems: analysis of developmental processes has to focus on intra-individual variation. Dev Psychobiol. 2008;50:60–9.